SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tomato who wrote (523)4/30/2001 8:09:29 PM
From: scaram(o)uche  Read Replies (1) of 1833
 
Chuckle.

Best fit? I'll let Peter paint the picture, and then I and others will fit it to given companies.

The issue of profit, such that the tax loss carryover can be used, would seem to rule out the sexiest of possibilities.

Peter..... could the yeasties and loss carryforward be sold separately from the cash, Axiom, and potential milestone/royalty flow? You said that the business had to be practiced by the company that purchased the carryforward. The "business" is the yeasties and ass'd stuff.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News